Ustekinumab

In the US, Ustekinumab (ustekinumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Psoriasis.

US matches:

• Ustekinumab


• Ustekinumab Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AC05

CAS registry number (Chemical Abstracts Service)

0815610-63-0

Chemical Formula

C6482-H10004-N1712-O2016-S46

Molecular Weight

145646

Therapeutic Category

Immunomodulator

Foreign Names

• Ustekinumabum (Latin)
• Ustekinumab (German)
• Ustékinumab (French)
• Ustekinumab (Spanish)

Generic Names

• Ustekinumab (OS: USAN)
• CNTO 1275 (IS)

Brand Names

• Stelara
  Centocor, United States; Janssen, Australia; Janssen, Germany; Janssen, Spain; Janssen, Luxembourg; Janssen-Cilag, United Kingdom; Janssen-Cilag International, Austria



• STELARA
  Janssen-Cilag, Sweden

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.